Description: Many patients and families ask about the Vyloy cost in India while exploring treatment options for advanced gastric cancer. Vyloy is a targeted therapy used along with chemotherapy for patients with HER2-negative gastric or gastroesophageal junction cancer whose tumors are CLDN18.2 positive. At present, Vyloy in India is not officially approved for commercial sale. It can only be accessed through the Named Patient Program (NPP) with a valid prescription from a qualified oncologist. Since the medicine is imported from countries where it is approved, the final cost depends on international pricing, dosage required, shipping charges, and regulatory paperwork. Because each patient’s treatment plan differs, the price is calculated on a case-by-case basis.
Category:
Tag: Vyloy availability in India